Profile
| Metric | Value |
|---|---|
| Full Name | Bristol-Myers Squibb Company |
| Ticker | NYSE: BMY |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | bms.com |
| Employees | 34,100 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $61.99 | |
| Price, 1D Change | +4.15% | |
| Market Cap | $126B | |
| TTM Dividend Yield | 4.02% | |
| PE Ratio | 20.93 | |
| Beta | 0.33 | |
| Revenue | $48B | |
| Revenue, 1Y Change | +7.32% | |
| EPS | -$4.41 | |
| EPS, 1Y Change | -214.31% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.63 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1000000:951777 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$4.41 | |
| EPS Estimate | N/A | $6.14 |
| EPS Est. Change | N/A | +239.00% |
| Revenue | $48.30B | |
| Revenue Estimate | N/A | $47.99B |
| Revenue Est. Change | N/A | -0.65% |
| Current Price | $61.99 | |
| Price Target | - | $60.00 |
| Price Tgt. Change | - | -3.21% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $7.39 | $3.86 | -47.74% | |
| $0.92 | -$4.41 | -580.82% | |
| $6.14 | N/A | +239.00% | |
| $6.01 | N/A | +236.16% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $44.71B | $45.01B | +0.66% | |
| $47.51B | $48.30B | +1.66% | |
| $47.99B | N/A | -0.65% | |
| $44.18B | N/A | -8.53% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +7.96% | |
| Price, 3Y | -16.83% | |
| Market Cap, 1Y | +8.30% | |
| Market Cap, 3Y | -18.40% | |
| Revenue, 1Y | +7.32% | |
| Revenue, 3Y | +4.13% | |
| EPS, 1Y | -214.31% | |
| EPS, 3Y | -241.70% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $61.99 | |
| SMA 200 | $48.55 | |
| SMA 200 vs Price | -21.68% | |
| SMA 50 | $54.01 | |
| SMA 50 vs Price | -12.87% | |
| Beta | 0.33 | |
| ATR | $1.40 | |
| 14-Day RSI | 77.21 | |
| 10-Day Volatility | 28.40% | |
| 1-Year Volatility | 29.49% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.63 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 3.87% | |
| Total Dividend | $2.40 | |
| $4.86B | ||
| -54.44% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $48.30B | |
| EPS | -$4.41 | |
| Gross Profit | $27.43B | |
| Gross Margin | 56.80% | |
| Operating Profit | $9.66B | |
| Operating Margin | -23.21% | |
| Net Income | -$8.93B | |
| Net Margin | -18.49% | |
| EBITDA | $19.31B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 3.13 | |
| 1.25 | ||
| 1.15 | ||
| - | ||
| 8 | ||
| 2.16 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 20.93 | |
| 2.63 | ||
| 6.80 | ||
| 8.47 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $16.33B | |
| $10.86B | ||
| $92.60B | ||
| $29.78B | ||
| $76.22B | ||
| $23.77B | ||
| Total Debt | $51.20B | |
| $2.23B | ||
| $3.60B |
Expenses
| Metric | Date | Value |
|---|---|---|
| $57.25B | ||
| $17.77B | ||
| $20.87B | ||
| $0.00 | ||
| $9.60B | ||
| $0.00 | ||
| $554.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $15.19B | ||
| -$21.35B | ||
| $5.13B | ||
| Capex | $1.25B | |
| $13.94B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| Citigroup | → | |
| Leerink Partners | → | |
| Scotiabank | → | |
| UBS | → | |
| Citigroup | → | |
| B of A Securities | → | |
| Morgan Stanley | → | |
| Guggenheim | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with BMY
FAQ
What is the ticker symbol for Bristol-Myers Squibb Company?
The ticker symbol for Bristol-Myers Squibb Company is NYSE:BMY
Does Bristol-Myers Squibb Company pay dividends?
Yes, Bristol-Myers Squibb Company pays dividends. The last payment was $0.63, with an ex-dividend date on January 2, 2026
What sector is Bristol-Myers Squibb Company in?
Bristol-Myers Squibb Company is in the Healthcare sector
What industry is Bristol-Myers Squibb Company in?
Bristol-Myers Squibb Company is in the General Drug Manufacturers industry
What country is Bristol-Myers Squibb Company based in?
Bristol-Myers Squibb Company is headquartered in United States
When did Bristol-Myers Squibb Company go public?
Bristol-Myers Squibb Company initial public offering (IPO) was on June 1, 1972
Is Bristol-Myers Squibb Company in the S&P 500?
Yes, Bristol-Myers Squibb Company is included in the S&P 500 index
Is Bristol-Myers Squibb Company in the NASDAQ 100?
No, Bristol-Myers Squibb Company is not included in the NASDAQ 100 index
Is Bristol-Myers Squibb Company in the Dow Jones?
No, Bristol-Myers Squibb Company is not included in the Dow Jones index
When was Bristol-Myers Squibb Company last earnings report?
Bristol-Myers Squibb Company's most recent earnings report was on February 5, 2026
When does Bristol-Myers Squibb Company report earnings?
The date for Bristol-Myers Squibb Company's next earnings report has not been announced yet
Data Sources & References
- BMY Official Website www.bms.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- BMY Profile on Yahoo Finance finance.yahoo.com/quote/BMY
- BMY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bmy
